Nuance Biotech
Manufacturing · China · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Block a Innovation Plaza No. 2007 Pingsh...Website
www.nuancebiotech.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
2
1
1
1
1
About Nuance Biotech
Nuance Biotech is a leading China based specialty pharmaceutical company headquartered in Shanghai. Nuance has been funded by a group of leading venture capital funds that includes Matrix Partners. The company was established in 2014 and has rapidly built a unique portfolio that includes several leading brands. The portfolio includes a series of products which are currently commercialized, in registration and an impressive portfolio currently in clinical development. Nuance has both a specialty TA focus as well as targeting surgery departments across leading hospitals in China. Led by a team of seasoned China based executives with a strong track record in China, the company is seeking to further strengthen its China position as well as its presence in the field of surgery. EXPAREL is the latest addition and represents a unique opportunity to strengthen its position in China.Explore more
Nuance Biotech Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Nuance Biotech your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Nuance Biotech, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Nuance Biotech launches new products
Check if Nuance Biotech has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Nuance Biotech
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Nuance Biotech has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Nuance Biotech recently announced quarterly report
Click to see if Nuance Biotech had a recent Job posting/layoffs
Check out if Nuance Biotech is spiking on competitors!
Recommended Actions
Reach out to Masked Content who joined Nuance Biotech as Masked Content
Find 3 more new buyers
Company Profile Activity
Activity Insights
Nuance Biotech is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Nuance Biotech is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Nuance Biotech.
Nuance Biotech financials insights
Gather financial insights about Nuance Biotech, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2018
Series A
$8M
Series B
$20M
2019
Series C
$2M
Nuance Biotech Tech Stack
A closer look at the technologies used by Nuance Biotech
Nuance Biotech News & Media
Nuance Announces series B fundraising led by C-Bridge Capital to commercialize high-value pharmaceuticals in China
SHANGHAI, China, June 27, 2018 (GLOBE NEWSWIRE) -- Nuance Biotech, a China-based specialty pharmaceutical company, today announced Series B fundraising of US$20 million with additional capital US$15 million tied to its acquisition of new products, led by C-Bridge Capital, a private equity firm focused on development and commercialization opportunities within the growing Chinese healthcare market, and Neo Zhang, Managing Director of C-Bridge Capital, will join the board of Nuance. The Series B roPacira Pharmaceuticals and Nuance Biotech Announce License Agreement for EXPAREL® in China
PARSIPPANY, N.J. and SHANGHAI, China, June 19, 2018 (GLOBE NEWSWIRE) -- Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) and Nuance Biotech Co. Ltd (Nuance) today announced that they have entered into an agreement with Nuance, a China based specialty pharmaceutical company, to advance the development and commercialization of EXPAREL® (bupivacaine liposome injectable suspension) in China. EXPAREL is a non-opioid option for achieving long-lasting pain control after surgery via infiltration into the surg
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Nuance Biotech
Sign Up For FreeTo access detailed company insights
Nuance Biotech is a leading China based specialty pharmaceutical company headquartered in Shanghai. Nuance has been funded by a group of leading venture capital funds that includes Matrix Partners. The company was established in 2014 and has rapidly built a unique portfolio that includes several leading brands. The portfolio includes a series of pr... Read More
